A Novel Cognitive Enhancing Drug for Borderline Personality Disorder
Condition: Borderline Personality DisorderInterventions: Drug: NMDA receptor antagonist (active drug); Other: Lactose packed capsule (inert/inactive arm)Sponsor: The AlfredNot yet recruiting - verified March 2014
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Borderline Personality Disorder | Research